Recent LXRX News
- Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 07/29/2024 09:44:55 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 07/29/2024 09:31:42 PM
- Lexicon Pharmaceuticals to Host Second Quarter 2024 Financial Results Conference Call and Webcast on August 1, 2024 • GlobeNewswire Inc. • 07/25/2024 12:00:00 PM
- Lexicon Pharmaceuticals Receives December 20, 2024 PDUFA Goal Date for Sotagliflozin Type 1 Diabetes NDA Resubmission • GlobeNewswire Inc. • 07/16/2024 12:00:00 PM
- New Published Data Highlights Potential Cost-Savings of INPEFA® (sotagliflozin) for Heart Failure • GlobeNewswire Inc. • 07/15/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/08/2024 09:27:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/08/2024 09:27:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/08/2024 01:15:18 PM
- Lexicon Board of Directors Appoints Mike Exton, Ph.D. as New Chief Executive Officer and Director • GlobeNewswire Inc. • 07/08/2024 01:15:00 PM
- Lexicon Pharmaceuticals Resubmits Sotagliflozin NDA for Type 1 Diabetes • GlobeNewswire Inc. • 06/21/2024 12:00:00 PM
- Data From Lexicon’s RELIEF-DPN 1 Phase 2 Study of LX9211 Published Today in Diabetes Care, a Peer-Reviewed Journal of the American Diabetes Association • GlobeNewswire Inc. • 06/19/2024 12:00:00 PM
- Analysis of INPEFA® (Sotagliflozin) Cost-Effectiveness Published in JACC: Heart Failure, the Peer-Reviewed Journal of the American College of Cardiology • GlobeNewswire Inc. • 06/18/2024 12:00:00 PM
- Findings on the Burdens of Diabetic Peripheral Neuropathic Pain (DPNP) Among Three Lexicon-Sponsored Presentations at the 84th Scientific Sessions of the American Diabetes Association • GlobeNewswire Inc. • 06/14/2024 12:00:00 PM
- Lexicon Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference 2024 • GlobeNewswire Inc. • 05/29/2024 11:30:00 AM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 05/14/2024 09:05:01 PM
- New Post-Hoc Analysis of Pooled Phase 3 Data Shows That INPEFA® (Sotagliflozin) Reduced Risk of Heart Failure Events in Patients With Preserved Ejection Fraction • GlobeNewswire Inc. • 05/14/2024 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/13/2024 08:05:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/13/2024 08:04:41 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/13/2024 08:03:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/13/2024 08:01:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/13/2024 08:00:44 PM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 05/10/2024 09:14:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/10/2024 08:15:54 PM
FEATURED Cannabix Technologies to Deliver Innovative Breath Logix Alcohol Screening Device to Texas, USA • Jul 29, 2024 9:07 AM
INDEXR AI Merges With Moon Equity Holdings Corp. (MONI), Creating a Leading-edge Technology Company • MONI • Jul 29, 2024 9:59 AM
BNCM AND DELEX UNVEIL POST-MERGER MANAGEMENT PLANS • BNCM • Jul 29, 2024 9:00 AM
Glidelogic Corp. Announces Revolutionary AI-Generated Content Copyright Protection Solution • GDLG • Jul 26, 2024 12:30 PM
Southern Silver Files NI43-101 Technical Report for its Updated Preliminary Economic Assessment for the Cerro Las Minitas Project • SSV • Jul 25, 2024 8:00 AM
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM